Abstract
Purpose
Central venous catheters emerged as a major risk factor for infectious complications in hemodialysis (HD) patients. We aimed to assess the incidence of bacteremia in catheter-dependent HD patients and to characterize its clinical and economic impact.
Methods
We retrospectively collected clinical data and healthcare costs from 15 months for 75 admitted catheter-dependent HD patients, to document the type of bacteremia (complicated or not), pathogen and inflammation.
Results
Bacteremia (97 % with Staphylococcus aureus, 33 % methicillin-resistant) was present in 51 % patients, with an overall infections incidence of 5.79 per 1,000 catheter-days. Metastatic complications occurred in 21 % of bacteremic patients and were associated with higher mortality (38 vs. 4 %; p = 0.001). Although, in patients starting dialysis on catheter (41 %) as compared to those using catheter as bridge angioaccess, inflammation (higher C-reactive protein; p = 0.006) and anemia (lower Hb; p = 0.008) were more pronounced, bacteremia occurred in a lower proportion (32 vs. 64 %, p = 0.007). The total medical costs were 47 % higher in patients with complicated bacteremia than in those without bacteremia (p = 0.008) and 45 % higher in patients starting HD on catheter than in those using catheter as bridge angioaccess (p = 0.002).
Conclusions
Despite the limitations resulting from retrospective cross-sectional single-center design, our study suggests that patients already on HD who required catheters as bridge angioaccess were more prone to bacteremia. This highlights the importance of close angioaccess monitoring to avoid unnecessary catheter usage. A similar increase in costs when initiating dialysis on catheter as in case of complicated bacteremia strongly supports the initial placement of a native arteriovenous fistula.
Similar content being viewed by others
References
Bloembergen WE, Port FK (1996) Epidemiological perspective on infections in chronic dialysis patients. Adv Ren Replace Ther 3:201–207
Nassar GM, Ayus J (2001) Infectious complications of the hemodialysis access. Kydney Int 60:1–13
Katneni R, Hedayati S (2007) Central venous catheter-related bacteremia in chronic hemodialysis patients: epidemiology and evidence-based management. Nat Clin Pract Nephrol 3(5):256–266
Taylor G, Gravel D, Johnston L (2004) Incidence of bloodstream infection in multicenter inception cohorts of hemodialysis patients. Am J Infect Control 32:155–160
Vandecasteele SJ, Boelaert JR, De Vriese AS (2009) Staphylococcus aureus infection in hemodialysis: what a nephrologist should know. Clin J Am Soc Nephrol 4:1388–1400
Lemaire X, Morena M, Leary-Moragues H et al (2009) Analysis of risk factors for catheter-related bacteremia in 2000 permanent dual catheters for hemodialysis. Blood Purif 28:21–28
Allon M (2004) Dialysis catheter-related bacteremia: treatment and prophylaxis. Am J Kidney Dis 44:779–791
Teehan GS, Ruthazer R, Balakrishnan VS, Snydman D, Jaber BL (2004) Iron storage indices and risk of bacterial infections in hemodialysis patients. Hemodial Int 8:226–232
Ramanathan V, Chiu EJ, Thomas JT et al (2007) Healthcare costs associated with hemodialysis catheter related infections: a single center experience. Infect Control Hosp Epidemiol 28:606–609
Nissenson AR, Dylan ML, Griffiths RI et al (2005) Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis. Am J Kidney Dis 46:301–308
Engemann JJ, Friedman JY, Reed SD et al (2005) Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol 26:534–539
Danese MD, Griffiths R, Dylan M, Yu HT, Dubois R, Nissenson R (2006) Mortality differences among organisms causing septicemia in hemodialysis patients. Hemodial Int 10:56–62
Al-Solaiman Y, Estrada E, Allon M (2011) The spectrum of infections in catheter-dependent hemodialysis patients. Clin J Am Soc Nephrol 6:2247–2252
Poole CV, Carlton D, Bimbo L, Allon M (2004) Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen. Nephrol Dial Transplant 19:1237–1244
Johnson LB, Jose J, Yousif F, Pawlak J, Saravolatz LD (2009) Prevalence of colonization with community-associated methicillin-resistant Staphylococcus aureus among end-stage renal disease patients and healthcare workers. Infect Control Hosp Epidemiol 30:4–8
Lederer SR, Riedelsdorf G, Schiffl H (2007) Nasal carriage of methicillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among out clinic haemodialysis patients. Eur J Med Res 12:284–288
Inrig JK, Reed S, Szczech LA et al (2006) Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia. Clin J Am Soc Nephrol 1(3):518–524
Marr KA, Kong L, Fowler VG et al (1998) Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients. Kidney Int 54:1694–1699
Marr KA (2000) Staphylococcus aureus bacteremia in patients undergoing hemodialysis. Semin Dial 13:23–29
Zimmerli W, Lew PD, Waldvogel FA (1984) Pathogenesis of foreign body infection. Evidence for a local granulocyte defect. J Clin Invest 73:1191–1200
Parienti JJ, Thirion M, Mégarbane B et al (2008) Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA 28:2413–2422
Tanriover B, Carlton D, Saddekni S et al (2000) Bacteremia associated with tunneled dialysis catheters: comparison of two treatment strategies. Kidney Int 57:2151–2155
Unver S, Atasoyu E, Evrenkaya TR, Ardic N, Ozyurt M (2006) Risk factors for the infections caused by temporary double-lumen hemodialysis catheters. Arch Med Res 37:348–352
Sanavi S, Ghods A, Afshar R (2007) Catheter associated infections in hemodialysis patients. Saudi J Kidney Dis Transpl 18:43–46
Goldstein SL, Ikizler TA, Zappitelli M, Silverstein DM, Ayus JC (2009) Non-infected hemodialysis catheters are associated with increased inflammation compared to arteriovenous fistulas. Kidney Int 76:1063–1069
Cappelli G, Tetta C, Canaud B (2005) Is biofilm a cause of silent chronic inflammation in haemodialysis patients? A fascinating working hypothesis. Nephrol Dial Transplant 20:266–270
Sherertz RJ, Carruth WA, Marosok RD, Espeland MA, Johnson RA, Solomon DD (1995) Contribution of vascular catheter material to the pathogenesis of infection: the enhanced risk of silicone in vivo. J Biomed Mater Res 29:635–645
Marosok R, Washburn R, Indorf A, Solomon D, Sheretz R (1996) Contribution of vascular catheter material to the pathogenesis of infection: depletion of complement by silicone elastomer in vitro. J Biomed Mater Res 30:245–250
Lee H, Manns B, Taub K et al (2002) Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis 40:611–622
Manns B, Tonelli M, Yilmaz S et al (2005) Establishment and maintenance of vascular access in incident hemodialysis patients: a prospective cost analysis. J Am Soc Nephrol 16:201–209
Conflict of interest
The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ştefan, G., Stancu, S., Căpuşă, C. et al. Catheter-related infections in chronic hemodialysis: a clinical and economic perspective. Int Urol Nephrol 45, 817–823 (2013). https://doi.org/10.1007/s11255-012-0244-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-012-0244-7